Sangamo Biosciences Inc. (SGMO)

Last Three Months

22-Aug-24 -- 21-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

45

0

0

+1

0

+2

0

+3

Two Year Chart

22-Nov-22 -- 21-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
27-Aug-24 4:38 PM View:	25-Aug-24 Payment of Exercise ($1.18K)	Willoughby Scott B. SVP, Gen. Counsel & Secretary		Sangamo Biosciences Inc. - SGMO	0% 832.8K to 830.0K	0	0	--	--	Show Txns Hide Txns

27-Aug-24 4:36 PM View:	25-Aug-24 Payment of Exercise ($6.44K)	MacRae Sandy President, CEO and Director Director		Sangamo Biosciences Inc. - SGMO	(1%) 2.54M to 2.53M	0	0	--	--	Show Txns Hide Txns

27-Aug-24 4:37 PM View:	25-Aug-24 Payment of Exercise ($1.18K)	Duraibabu Prathyusha SVP, Chief Financial Officer		Sangamo Biosciences Inc. - SGMO	0% 830.53K to 827.37K	0	0	--	--	Show Txns Hide Txns

27-Aug-24 4:37 PM View:	25-Aug-24 Payment of Exercise ($1.30K)	Dubois-Stringfellow Nathalie SVP-Chief Development Officer		Sangamo Biosciences Inc. - SGMO	0% 847.89K to 844.6K	0	0	--	--	Show Txns Hide Txns

27-Aug-24 4:38 PM View:	25-Aug-24 Payment of Exercise ($0.42K)	Pooler Amy VP, Head of Research		Sangamo Biosciences Inc. - SGMO	(1%) 195.12K to 193.92K	0	0	--	--	Show Txns Hide Txns